Caris Life Sciences’ ADAPT Biotargeting System Identifies a Key Cell Surface Regulator of MYC as the Molecular Target of a Cytotoxic Aptamer
Study Data Presented at AACR 2017 Annual Meeting Demonstrates the Ability of ADAPT Biotargeting System to Identify Molecular Targets for Anti-cancer Aptamers IRVING, Texas, Apr. 3, 2017 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced results of a study that demonstrate the ability
Read more →